about
The Danish National Registry for Biological Therapy in Inflammatory Bowel DiseaseThe incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data.A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitisUse of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice.A rare cause of severe hepatomegaly with an improving outcome.Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.Capsule endoscopy for the diagnosis and follow up of Crohn's disease: a comprehensive review of current status.Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn's Disease.Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.Poor Outcomes of Complicated Pouch-Related Fistulas after Ileal Pouch-Anal Anastomosis Surgery.Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.In vivo and in situ measurement and modelling of intra-body effective complex permittivity.Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.Letter: number of treatments with anti-TNF-α and reoperations in inflammatory bowel disease.Sexual function and body image are similar after laparoscopy-assisted and open ileal pouch-anal anastomosis.Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine.Home parenteral nutrition increases fat free mass in patients with incurable gastrointestinal cancer. Results of a randomized controlled trial.Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.Vedolizumab safety in pregnancy and newborn outcomes.Inter-observer agreement for detection of small bowel Crohn's disease with capsule endoscopy.Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn's disease.Circulating microRNAs as biomarkers of adult Crohn's disease.Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyNatural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyHigh sensitivity of quick view capsule endoscopy for detection of small bowel Crohn's disease
P50
Q28073880-91330157-A8BF-4798-ADE0-A3F381B7B3ACQ30787053-9046883B-C4F6-4066-9D23-4642090BB282Q33749513-880D22B3-1DC5-4461-93F8-43FC7BBDEB57Q34437894-CEF0FE56-E563-4868-AFEB-58DA7DF53728Q38410127-2B71E925-7C83-4041-82AA-487813D67D37Q38565782-A9E941A9-7B94-4C7C-929B-A532464DD668Q38766225-EDE7026A-09E8-4406-ABA6-CEFF22D47742Q38789632-725B5FF6-1269-428D-ABB0-2331E7804790Q38933876-1314CF31-D4CC-46D1-9B2C-9ECC6E683956Q39153608-71327062-67CD-49E1-ACA4-3935E29515DDQ40063321-B5DF9CDC-F395-4232-A9DF-F4665F3F7B20Q40272195-B80BFCB1-7ED4-4E85-AC50-6AADB6DA3F7CQ40657731-89D153E4-E80D-4246-AE73-D16BDA57EFD0Q40720844-1D91889A-8CDD-4E03-B1A5-9FC34B0DF825Q41178049-348DAEB6-A8B1-4D8D-A6C7-7124B9574FBCQ42127776-7394CF9E-B933-41DF-94A5-BE53E7F3292EQ42650416-15796987-988C-49A6-BDBE-A0CC38D55C3CQ42701706-83C2495B-A4CF-4AB2-AF5A-E21E9EEF96DAQ44295532-788BCECE-3B9E-479F-956C-CE90C70F1056Q44332424-EB2F2403-7D87-4182-B293-368B2EE9FD11Q44775146-DB2A1B12-CD12-463B-B85A-258AEF4A4814Q45905337-1EE0DEDF-CAA3-4664-82B3-FD294C5DEB30Q46213403-69CB5B3E-0AAF-415D-95BB-3E62B8E198ABQ48080578-263ADE7C-E6CE-49D3-843E-BFA2648A219BQ48085176-5160F565-F9E7-4A5E-BAF8-E5D3D4F8962CQ48309127-D9964471-0888-42BF-9316-BB2879384E6EQ49496876-422C5F54-9ED2-42E6-9979-02BCDA568695Q50036719-09D21BCE-90AE-4079-88BB-432ADD23D1E4Q50159929-502CB386-1B72-4A7C-8B1F-B09070A1677CQ50960517-E4B47C1F-1339-4BA9-AA76-F5012BC0C490Q52673711-BC1837A8-625C-48E4-8BF9-66B60E17E932Q52842668-1EB3320E-B2EE-4E6B-BF5B-41B8CF6E256AQ53066687-38C99742-BDCF-4EFB-B5C0-C13769495DFCQ53079724-3D5B0DFB-043C-41EF-A5FD-A003CBC87968Q53203453-4F4456B5-BE25-4573-836E-0F43DB6A77F0Q53399822-8178732A-F731-4773-AAD9-02210D98001CQ53828369-FB387440-02C1-40D2-88A4-AE1B12497E86Q56761522-9535165D-CF26-4172-AACA-4925F62952D4Q56982023-9520B9BC-AC0C-49F1-8034-A6ACF8888E8AQ57110545-FFB6039E-14A5-453E-BECA-57DC7AA5C9E4
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-8148-6572
@en
name
Jens Kjeldsen
@ast
Jens Kjeldsen
@en
Jens Kjeldsen
@es
Jens Kjeldsen
@nl
type
label
Jens Kjeldsen
@ast
Jens Kjeldsen
@en
Jens Kjeldsen
@es
Jens Kjeldsen
@nl
prefLabel
Jens Kjeldsen
@ast
Jens Kjeldsen
@en
Jens Kjeldsen
@es
Jens Kjeldsen
@nl
P106
P31
P496
0000-0001-8148-6572